Richard D. Baird

Enhanced detection of circulating tumor DNA by fragment size analysis

Florent Moulière, Dineika Chandrananda, Anna Piskorz et al. · Science Translational Medicine · 2018 · 1.1K citations · Full text

Medicine, Molecular Biology, Oncology +13

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Shahneen Sandhu, William R. Schelman, George Wilding et al. · The Lancet Oncology · 2013 · 558 citations

Medicine, Oncology, Pharmacology +12

First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors

Timothy A. Yap, Yan Li, Amita Patnaik et al. · Journal of Clinical Oncology · 2011 · 543 citations

Medicine, Oncology, Pharmacology +17

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds

Alejandra Bruna, Oscar M. Rueda, Wendy Greenwood et al. · Cell · 2016 · 468 citations · Full text

Medicine, Cancer Biology, Oncology +15

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Peter Schmid, Jacinta Abraham, Stephen Chan et al. · Journal of Clinical Oncology · 2019 · 389 citations · Full text

Medicine, Oncology, Pharmacology +16